Trial · NCT06088199
A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
NCT06088199, Phase 3, Completed, Amgen
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis. Trials, record NCT06088199. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT06088199
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- A Study of Apremilast in Pediatric Participants in Children With Mild to Moderate Plaque Psoriasis
- NCT number
- NCT06088199
- Status
- Completed
- Phases
- Phase 3
- Enrollment
- 51 participants, actual
- Lead sponsor
- Amgen
- Conditions
- Plaque Psoriasis
- Interventions
- Apremilast
- First posted
- 2023-10-18
- Last updated
- 2026-10-23
Source ClinicalTrials.gov
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Number of Participants With Treatment-emergent Adverse Events | Day 1 up to approximately 285 days | |
| Secondary | Growth and Development as Assessed by Height | Day 1 up to approximately 285 days | |
| Secondary | Growth and Development as Assessed by Weight | Day 1 up to approximately 285 days | |
| Secondary | Growth and Development as Assessed by Body Mass Index (BMI) | Day 1 up to approximately 285 days | |
| Secondary | Columbia-Suicide Severity rating Scale (C-SSRS) | Day 1 to Day 225 | |
| Secondary | Tanner Staging of Sexual Maturity | Day 1 and Day 225 | |
| Secondary | Number of Participants With Psoriasis Flare | Up to approximately 285 days | |
| Secondary | Number of Participants With Psoriasis Rebound | Up to approximately 285 days | |
| Secondary | Number of Participants Experiencing Diarrhea Sympotms as Assessed by Stool Diaries | Day 1 to Day 225 | |
| Secondary | Number of Participants with Clinically Significant Changes in Laboratory Parameters | Up to approximately 225 days |
1 to 10 of 11Source ClinicalTrials.gov
See all 11 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT06088199
GET https://conductscience.org/api/trials/v1/NCT06088199/registered